نمایش پرونده ساده آیتم

dc.contributor.authorKheradmand, A
dc.contributor.authorNayebi, AM
dc.contributor.authorJorjani, M
dc.contributor.authorKhalifeh, S
dc.contributor.authorHaddadi, R
dc.date.accessioned2018-08-26T05:37:49Z
dc.date.available2018-08-26T05:37:49Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/39943
dc.description.abstractOver production of reactive oxygen species (ROS) is postulated to be the main contributor in degeneration of nigrostriatal dopaminergic neurons. In this study we investigated the effects of WR1065, a free radical scavenger, on motor imbalance, oxidative stress parameters and inflammatory cytokines in CSF and brain of hemi-parkinsonian rats. Lesion of dopaminergic neurons was done by unilateral infusion of 6-hydroxydopamine into the central region of the substentia nigra pars compacta (SNc) to induce hemi-parkinsonism and motor imbalance in rats. WR1065 (20, 40 and 80?g/2?l/rat) was administered three days before 6-OHDA administration. After three weeks behavioral study was performed and then brain and CSF samples were collected to assess tumor necrosis factor (TNF?), interlukin (IL-1?), reduced glutathione (GSH), and malondialdehyde (MDA). WR1065 pre-treatment in rats before receiving 6-OHDA, improved significantly motor impairment and caused reduction of MDA and inflammatory cytokines TNF? and IL-1? levels, while GSH level significantly increased when compared with lesioned rats. Our study indicated that WR1065 could improve 6-OHDA-induced motor imbalance. Furthermore, it decreased lipid peroxidation and inflammatory cytokines and restored the level of GSH up to normal range. We suggest that WR1065 can be proposed as a potential neuroprotective agent in motor impairments of PD. However to prove this hypothesis more clinical trial studies should be done.
dc.language.isoEnglish
dc.relation.ispartofNeuroscience letters
dc.subjectAnimals
dc.subjectDisease Models, Animal
dc.subjectGlutathione
dc.subjectInflammation
dc.subjectInterleukin-1beta
dc.subjectLipid Peroxidation
dc.subjectMale
dc.subjectMalondialdehyde
dc.subjectMercaptoethylamines
dc.subjectMotor Activity
dc.subjectNeuroprotective Agents
dc.subjectOxidative Stress
dc.subjectOxidopamine
dc.subjectParkinsonian Disorders
dc.subjectPars Compacta
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectTumor Necrosis Factor-alpha
dc.titleEffects of WR1065 on 6-hydroxydopamine-induced motor imbalance: Possible involvement of oxidative stress and inflammatory cytokines.
dc.typearticle
dc.citation.volume627
dc.citation.spage7
dc.citation.epage12
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.1016/j.neulet.2016.05.040


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم